136 related articles for article (PubMed ID: 22201953)
1. Diagnostic and therapeutical role of vitamin D in chronic hepatitis C virus infection.
Cacopardo B; Camma C; Petta S; Pinzone MR; Cappellani A; Zanghi A; Nicolosi A; Nunnari G
Front Biosci (Elite Ed); 2012 Jan; 4(4):1276-86. PubMed ID: 22201953
[TBL] [Abstract][Full Text] [Related]
2. Effect of vitamin D supplementation on sustained virological response in genotype 1/4 chronic hepatitis C treatment-naïve patients from India.
Behera MK; Shukla SK; Dixit VK; Nath P; Abhilash VB; Asati PK; Jain AK
Indian J Med Res; 2018 Aug; 148(2):200-206. PubMed ID: 30381543
[TBL] [Abstract][Full Text] [Related]
3. Vitamin D deficiency and vitamin D therapy in chronic hepatitis C.
Ladero JM; Torrejón MJ; Sánchez-Pobre P; Suárez A; Cuenca F; de la Orden V; Devesa MJ; Rodrigo M; Estrada V; López-Alonso G; Agúndez JA
Ann Hepatol; 2013; 12(2):199-204. PubMed ID: 23396730
[TBL] [Abstract][Full Text] [Related]
4. The hepatic expression of vitamin D receptor is inversely associated with the severity of liver damage in genotype 1 chronic hepatitis C patients.
Petta S; Grimaudo S; Tripodo C; Cabibi D; Calvaruso M; Di Cristina A; Guarnotta C; Macaluso FS; Minissale MG; Marchesini G; Craxì A
J Clin Endocrinol Metab; 2015 Jan; 100(1):193-200. PubMed ID: 25268393
[TBL] [Abstract][Full Text] [Related]
5. Liver vitamin D receptor, CYP2R1, and CYP27A1 expression: relationship with liver histology and vitamin D3 levels in patients with nonalcoholic steatohepatitis or hepatitis C virus.
Barchetta I; Carotti S; Labbadia G; Gentilucci UV; Muda AO; Angelico F; Silecchia G; Leonetti F; Fraioli A; Picardi A; Morini S; Cavallo MG
Hepatology; 2012 Dec; 56(6):2180-7. PubMed ID: 22753133
[TBL] [Abstract][Full Text] [Related]
6. Low vitamin D serum level is related to severe fibrosis and low responsiveness to interferon-based therapy in genotype 1 chronic hepatitis C.
Petta S; Cammà C; Scazzone C; Tripodo C; Di Marco V; Bono A; Cabibi D; Licata G; Porcasi R; Marchesini G; Craxí A
Hepatology; 2010 Apr; 51(4):1158-67. PubMed ID: 20162613
[TBL] [Abstract][Full Text] [Related]
7. Integrative role of vitamin D related and Interleukin-28B genes polymorphism in predicting treatment outcomes of Chronic Hepatitis C.
El-Derany MO; Hamdy NM; Al-Ansari NL; El-Mesallamy HO
BMC Gastroenterol; 2016 Feb; 16():19. PubMed ID: 26911666
[TBL] [Abstract][Full Text] [Related]
8. Molecular assessment of vitamin D receptor polymorphism as a valid predictor to the response of interferon/ribavirin-based therapy in Egyptian patients with chronic hepatitis C.
Abdelsalam A; Rashed L; Salman T; Hammad L; Sabry D
J Dig Dis; 2016 Aug; 17(8):547-553. PubMed ID: 27128845
[TBL] [Abstract][Full Text] [Related]
9. Relationship of vitamin D status with advanced liver fibrosis and response to hepatitis C virus therapy: a meta-analysis.
García-Álvarez M; Pineda-Tenor D; Jiménez-Sousa MA; Fernández-Rodríguez A; Guzmán-Fulgencio M; Resino S
Hepatology; 2014 Nov; 60(5):1541-50. PubMed ID: 24975775
[TBL] [Abstract][Full Text] [Related]
10. Correlation between vitamin D levels and apoptosis in geriatric patients infected with hepatitis C virus genotype 4.
Gabr SA; Alghadir AH; Allam AA; Ajarem J; Al-Basher G; Abdel-Maksoud MA; Ghfar AA; Aboud A
Clin Interv Aging; 2016; 11():523-33. PubMed ID: 27217734
[TBL] [Abstract][Full Text] [Related]
11. Association of vitamin D receptor gene polymorphisms with response to peginterferon plus ribavirin in Asian patients with chronic hepatitis C.
Hung CH; Hu TH; Lu SN; Chen CH; Wang JH; Lee CM
J Formos Med Assoc; 2016 Apr; 115(4):278-83. PubMed ID: 26725771
[TBL] [Abstract][Full Text] [Related]
12. Vitamin D-related gene polymorphism predict treatment response to pegylated interferon-based therapy in Thai chronic hepatitis C patients.
Thanapirom K; Suksawatamnuay S; Sukeepaisarnjaroen W; Tangkijvanich P; Treeprasertsuk S; Thaimai P; Wasitthankasem R; Poovorawan Y; Komolmit P
BMC Gastroenterol; 2017 Apr; 17(1):54. PubMed ID: 28415985
[TBL] [Abstract][Full Text] [Related]
13. Effects of vitamin D supplements in patients with chronic hepatitis C: a randomized, multi-center, open label study.
Jeong JY; Jun DW; Park SJ; Sohn JH; Kim SG; Lee SW; Jeong SW; Kim MY; Kim W; Shim JJ; Kim HS; Suk KT; Ahn SB
Korean J Intern Med; 2020 Sep; 35(5):1074-1083. PubMed ID: 31710801
[TBL] [Abstract][Full Text] [Related]
14. Vitamin D levels and IL28B polymorphisms are related to rapid virological response to standard of care in genotype 1 chronic hepatitis C.
Petta S; Ferraro D; Cammà C; Cabibi D; Di Cristina A; Di Marco V; Di Stefano R; Grimaudo S; Mazzola A; Levrero M; Scazzone C; Craxì A
Antivir Ther; 2012; 17(5):823-31. PubMed ID: 22505587
[TBL] [Abstract][Full Text] [Related]
15. Predictors of early and sustained virological response of viral hepatitis C.
Ghenea AE; Ungureanu AM; Turculeanu A; Popescu M; Carsote M; Ţieranu ML; Ţieranu EN; Vasile CM; Cioboată R; Udriştoiu AL; Alexandru DO; Sălan AI; Drocaş AI
Rom J Morphol Embryol; 2020; 61(4):1185-1192. PubMed ID: 34171067
[TBL] [Abstract][Full Text] [Related]
16. Vitamin D supplementation improves sustained virologic response in chronic hepatitis C (genotype 1)-naïve patients.
Abu-Mouch S; Fireman Z; Jarchovsky J; Zeina AR; Assy N
World J Gastroenterol; 2011 Dec; 17(47):5184-90. PubMed ID: 22215943
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of vitamin D supplementation in combination with conventional antiviral therapy in patients with chronic hepatitis C infection: a meta-analysis of randomised controlled trials.
Kim HB; Myung SK; Lee YJ; Park BJ;
J Hum Nutr Diet; 2018 Apr; 31(2):168-177. PubMed ID: 28833855
[TBL] [Abstract][Full Text] [Related]
18. Handgrip Strength and Vitamin D as Predictors of Liver Fibrosis and Malnutrition in Chronic Hepatitis C Patients.
Gabr SA; Alghadir AH
Dis Markers; 2021; 2021():6665893. PubMed ID: 33884041
[TBL] [Abstract][Full Text] [Related]
19. Association of serum vitamin B12 levels with stage of liver fibrosis and treatment outcome in patients with chronic hepatitis C virus genotype 1 infection: a retrospective study.
Mechie NC; Goralzcyk AD; Reinhardt L; Mihm S; Amanzada A
BMC Res Notes; 2015 Jun; 8():260. PubMed ID: 26109044
[TBL] [Abstract][Full Text] [Related]
20. Gadolinium-ethoxybenzyl-diethylenetriamine penta-acetic acid-enhanced magnetic resonance imaging for evaluating fibrosis regression in chronic hepatitis C patients after direct-acting antiviral.
Li XH; Huang R; Yang M; Wang J; Gao YH; Jin Q; Ma DL; Wei L; Rao HY
World J Gastroenterol; 2022 May; 28(20):2214-2226. PubMed ID: 35721884
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
